Skip to main content
ConductScienceScienceDex

John David O'Neill

NIH Rank #2670
Unclaimed recordClaim profile
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 12425690Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

NIH Funding · FY2025

Linked Award Amount
$3.5M
Full award amounts, FY2025
Award Records
3
Records listing this PI
Award-Linked Rank
#2,670
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for John David O'Neill. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing John David O'Neill as a PI. Multi-PI records show the full award amount for context.

  • 1R44HL182545-01R44
    Translational development and clinical evaluation of a bioengineered human lung graft for clinical transplantation
    Xylyx Bio, Inc.
    $1.5M
    award amount
  • 4R44DK139877-02R44
    Liver fibrosis cell-based assay platform: integrating patient-derived fibrotic liver ECM with primary stellate cells, Kupffer cells, and hepatocytes to accelerate anti-fibrotic drug development
    Xylyx Bio, Inc.
    $967.7K
    award amount
  • 5R44CA287881-02R44
    Multi-organ metastatic breast cancer cell-based assay platform that models organotropic metastases using patient organoids in human tissue-derived ECMs to accelerate anti-metastatic drug development
    Xylyx Bio, Inc.
    $966.4K
    award amount

Award organization

Organizations that administered FY2025 awards listing John David O'Neill as a PI.

FY2025 award administered by Xylyx Bio, Inc. (NY).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Xylyx Bio, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2025
    $1M Cumulative Funding
  4. 2025
    $2M Cumulative Funding
  5. 2025
    Entered Top 50% Nationally
    Ranked #2670
  6. 2025
    Entered Top 25% Nationally
    Ranked #2670

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as John David O'Neill.

Ciara M Shaver
Xylyx Bio, Inc.
1
shared award
Matthew Dominic Bacchetta
Xylyx Bio, Inc.
1
shared award

Explore further

Find collaborators for John David O'Neill

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →